Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06296914 · ClinicalTrials.gov registry record · NA
A MHealth System for Patients with POTS
A NA study of POTS - Postural Orthostatic Tachycardia Syndrome, sponsored by Jami Warren.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06296914 is a NA study of POTS - Postural Orthostatic Tachycardia Syndrome that has completed, run by Jami Warren. The registered enrollment target is 20 participants, below the 84-participant average among 5 other POTS - Postural Orthostatic Tachycardia Syndrome trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06296914, a NA study of POTS - Postural Orthostatic Tachycardia Syndrome, has completed, sponsored by Jami Warren.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Postural Orthostatic Tachycardia Syndrome (POTS) affects approximately 500,000 - 3 million Americans. This number will only increase due to the large number of patients experiencing POTS due to "long COVID." POTS patients experience several symptoms, including tachycardia, palpitations, dizziness, and pre-syncope or syncope, among others. POTS can be very debilitating and not only affect patients physically but also emotionally and financially. It takes an average of four years and seven doctors for POTS patients to achieve a diagnosis and it is often a frustrating and negative experience fraught with misdiagnoses, stigma, and depression and anxiety. Recent research demonstrates that mHealth technology may be one way that POTS patients can improve their experience in the healthcare system by providing objective data to their healthcare providers. Patients may also better take care of themselves through symptom monitoring and instant patient education via mHealth technology. The two study aims are: 1) Developing a mHealth app to improve the delay to diagnosis and the quality of life of POTS patients; and 2) Evaluate the usability and feasibility of the mHealth app and study design. To achieve these aims, researchers in this study will work with a programmer and leaders from the mHealth Application Modernization and Mobilization Alliance (MAMMA) and stakeholders (patients, caregivers, and providers) to co-design a mHealth app for POTS patients, including key educational components guided by the IDEA model, an instructional risk communication approach. A group of diagnosis-seeking POTS (n=20) patients will pilot test the app and provide feedback for improvement as well as evaluate its usability. Results from this study will allow researchers to acquire necessary data to apply for external funding to conduct a larger clinical trial to evaluate its influence on health outcomes, such as patient experience during visits with physicians, perceived stigma, and time to diagno
Conditions Studied
Interventions
- DEVICE POTSapp
- DEVICE Waitlist Control
Study Locations (1)
Kentucky
- University of Kentucky - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-02-20 |
| Est. Completion | 2025-02-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06296914
The ClinicalTrials.gov registry entry for NCT06296914 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 84-participant average among 5 other POTS - Postural Orthostatic Tachycardia Syndrome trials with a reported enrollment target (76% lower). The listed sponsor is Jami Warren, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with POTS - Postural Orthostatic Tachycardia Syndrome appearing as the primary indexed condition, and to 2 interventions - of which POTSapp is the first listed.
NCT06296914 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.
Frequently Asked Questions
What is clinical trial NCT06296914 about?
NCT06296914 is a clinical study titled "A MHealth System for Patients with POTS". Postural Orthostatic Tachycardia Syndrome (POTS) affects approximately 500,000 - 3 million Americans. This number will only increase due to the large number of patients experiencing POTS due to "long COVID." POTS patients experience several symptoms, including tachycardia, palpitations, dizziness, a...
What is the current status of trial NCT06296914?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2024-02-20. Estimated completion is 2025-02-24.
What conditions does trial NCT06296914 study?
This clinical trial studies the following conditions: POTS - Postural Orthostatic Tachycardia Syndrome.
What interventions are being tested in trial NCT06296914?
The interventions under investigation include: POTSapp (DEVICE), Waitlist Control (DEVICE).
Who is sponsoring clinical trial NCT06296914?
This trial is sponsored by Jami Warren, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06296914 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for POTS - Postural Orthostatic Tachycardia Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Long COVID Immune Profiling
RECRUITING · NA
-
Pathophysiology of Dysautonomia and Postural Tachycardia Syndrome (POTS) in Post-viral Syndromes and COVID-19
ACTIVE NOT RECRUITING · NA
-
Non-invasive Vagal Neurostimulation (nVNS) in Adolescents With Postural Orthostatic Tachycardia Syndrome (POTS)
COMPLETED · NA
-
Does a Periaqueductal Gray-vagus Nerve Interface Malfunction Explain the Nat hx With Its Numerous Co-morbidities?
RECRUITING
-
Restoring Iron Deficiency in POTS
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.